Survival Outcomes of Uterine Malignancies in Chinese Population

Lei Li10,000 enrolled

Overview

This study aims to determine survival outcomes (overall survival and progression-free survival) of primary uterine malignancies in China and relevant risk factors in a prospective cohort study.

Study Type

OBSERVATIONAL

Enrollment

10,000

Conditions

Endometrial Neoplasms Survival

Interventions

Follow-up for death and recurrenceOTHER

All patients are followed up to determine definite date of diagnosis, recurrence and death.

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * Primary uterine malignancies. Exclusion Criteria: * Metastatic malignancies to uterine corpus

Locations (1)

Lei Li

Beijing, China/Beiing, China

RECRUITING

Outcomes

Primary Outcomes

Overall survival

Survival duration from diagnosis to death

Time frame: 5 years

Progression-free survival

Survival duration from last treatment after remission to recurrence

Time frame: 5 years

Central Contacts

Lei Li, MD

CONTACT

13911988831 lileigh@163.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.